Finally, we delineated that p40 mAb treatment stimulated tumor-associated M1 macrophages, decreased tumor-associated M2 macrophages, and suppressed the TGFβ axis, leading to the regression of TNBC tumor in a PDX mouse model. Here, TGFB1 is linked to neoplasm.